NRG-CC003 - Protocol Reopening

 

Effective immediately, NRG-CC003, “A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer”, has been reopened to patient accrual.

The analysis of intracranial relapse rate of hippocampal avoidance during whole brain radiation (HA-PCI) compared to PCI, for the Phase II component of the study, has been completed. The study is now reopened to the Phase III component to determine whether HA-PCI reduces the likelihood of 6-month deterioration from baseline.


The protocol documents are located on the CTSU website.


Please distribute this information to the appropriate personnel at participating affiliate/NCORP component institutions.



View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse